WC
PTLA

Weatherbie Capital’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Weatherbie Capital’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$13.4M Buy
+598,814
New +$11.7M 1.69% 26

Other funds holding PTLA

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Weatherbie Capital's PTLA Position: Q4 2016 in Review

Weatherbie Capital opened a new position in Portola Pharmaceuticals, Inc. (PTLA) in Q4 2016: 598,814 shares worth $13.4M. The stake represents 1.69% of the portfolio and ranks #26 among its holdings.

150 funds tracked by Wall St. Rank hold PTLA as of Q4 2016.

  • Weatherbie Capital held 598,814 shares of Portola Pharmaceuticals, Inc. worth $13.4M as of Q4 2016.
  • Portola Pharmaceuticals, Inc. was a new Weatherbie Capital position in Q4 2016.
  • Portola Pharmaceuticals, Inc. made up 1.69% of Weatherbie Capital's portfolio in Q4 2016, its #26 holding.
  • 150 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2016.

Based on Weatherbie Capital's 13F filing for Q4 2016, filed 14 Feb 2017.